EVALUATION OF HYPOTENSION AND ALLERGIC REACTION WITH PARENTERAL DROTAVERINE IN A TERTIARY CARE HOSPI

2017-11-15 2017-11-20 2017-12-05 3/29/2025 9:06:54 AM Canadian Journal of Applied Sciences 7 2017 Original research article 1 4 2017 Can J App Sci (2017 ). 7. 01-04 http://dx.doi.org/10.21065/1925-7430.7.1 English Sidrah Andleeb, Eman Tahir, Omar Akhlaq Bhutta, Shahbaz Ahmad Khan, Saba Mazhar : Drotaverine, visceral pain, hypotension Background: Drotaverine is an excellent anti-spasmodic and a vital drug for relieving spastic visceral pain. However, the incidence of hypotension and allergic skin reactions is a concern with drotaverin’es use. Aim: This study was intended to evaluate the risk of adverse effects with drotaverine in hospital patients. Method: It was a retrospective cross-sectional study for the total cases on drotaverine inj. for the year 2017. Data collection form was used. Results: 1 out of a total of 62 patients suffered hypotension after administration of drotaverine injection (0.016%). Patient suffering hypotension was on dimenhydrinate injection q8hrs. regularly. There was no case of allergic skin reaction with the use. Conclusion: Use of drotaverine is safe with due consideration to mild risk of hypotension. Regular use of hypotensive drugs should be watched for while using drotaverine.